Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2021
|
Steinar J Engelsen |
BUY
Grant, award, or other acquisition
|
Direct |
7,558
+2.41%
|
-
|
|
May 12
2021
|
John Soriano Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,086
+16.12%
|
-
|
|
May 12
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,448
+15.23%
|
-
|
|
May 12
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,810
+7.19%
|
-
|
|
May 12
2021
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
28,344
+12.0%
|
-
|
|
May 12
2021
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,172
+28.96%
|
-
|
|
May 12
2021
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,172
+37.76%
|
-
|
|
May 12
2021
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,172
+11.17%
|
-
|
|
May 12
2021
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,558
+3.09%
|
-
|
|
Mar 16
2021
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-7.71%
|
$1,800,000
$36.5 P/Share
|
|
Mar 16
2021
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.88%
|
$150,000
$3.4 P/Share
|
|
Mar 11
2021
|
John Soriano Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
23,717
-44.34%
|
$948,680
$40.0 P/Share
|
|
Mar 11
2021
|
John Soriano Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,717
+30.72%
|
$711,510
$30.86 P/Share
|
|
Mar 10
2021
|
John Soriano Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
500
-1.65%
|
$20,000
$40.0 P/Share
|
|
Mar 10
2021
|
John Soriano Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.62%
|
$15,000
$30.86 P/Share
|
|
Mar 09
2021
|
John Soriano Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
44,912
-33.36%
|
$1,796,480
$40.38 P/Share
|
|
Mar 09
2021
|
John Soriano Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,912
+24.99%
|
$988,064
$22.84 P/Share
|
|
Mar 08
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,479
-5.43%
|
$94,202
$38.92 P/Share
|
|
Mar 08
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,709
+9.35%
|
$94,180
$20.49 P/Share
|
|
Mar 04
2021
|
Steinar J Engelsen |
BUY
Open market or private purchase
|
Direct |
2,710
+0.9%
|
$97,560
$36.9 P/Share
|
|
Feb 09
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,150
-9.72%
|
$681,750
$45.0 P/Share
|
|
Feb 09
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,150
+8.86%
|
$151,500
$10.85 P/Share
|
|
Feb 08
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,400
-4.35%
|
$275,200
$43.95 P/Share
|
|
Feb 08
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,400
+4.17%
|
$64,000
$10.85 P/Share
|
|
Jan 26
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,600
-1.81%
|
$114,400
$44.04 P/Share
|
|
Jan 26
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+1.78%
|
$26,000
$10.85 P/Share
|
|
Jan 25
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
21,000
-6.86%
|
$903,000
$43.4 P/Share
|
|
Jan 25
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+6.36%
|
$210,000
$10.85 P/Share
|
|
Jan 21
2021
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
1,031
+50.0%
|
-
|
|
Jan 21
2021
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
1,031
-0.22%
|
-
|
|
Jan 21
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
20,000
-6.63%
|
$820,000
$41.51 P/Share
|
|
Jan 21
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.22%
|
$200,000
$10.85 P/Share
|
|
Jan 20
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.63%
|
$390,000
$39.87 P/Share
|
|
Jan 20
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.22%
|
$100,000
$10.85 P/Share
|
|
Jan 12
2021
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
2,541
-1.09%
|
-
|
|
Jan 07
2021
|
John Soriano Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,509
+15.61%
|
-
|
|
Jan 07
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,346
+15.22%
|
-
|
|
Jan 07
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,183
+6.13%
|
-
|
|
Jan 07
2021
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,039
+10.93%
|
-
|
|
Jan 07
2021
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,019
+10.06%
|
-
|
|
Jan 07
2021
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,183
+50.0%
|
-
|
|
Jan 07
2021
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,019
+34.85%
|
-
|
|
Jan 04
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-2.64%
|
$30,030
$33.42 P/Share
|
|
Jan 04
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-0.49%
|
$21,450
$33.42 P/Share
|
|
Jan 04
2021
|
William Lewis Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,963
-1.85%
|
$97,779
$33.42 P/Share
|
|
Jan 04
2021
|
Roger Adsett Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-1.38%
|
$40,359
$33.42 P/Share
|
|
Jan 03
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
949
-2.68%
|
$31,317
$33.29 P/Share
|
|
Jan 03
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,814
-1.35%
|
$59,862
$33.29 P/Share
|
|
Jan 03
2021
|
John Soriano Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
949
-3.76%
|
$31,317
$33.29 P/Share
|
|
Jan 03
2021
|
William Lewis Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,255
-2.58%
|
$140,415
$33.29 P/Share
|